Digenic inheritance of mutations in SPG7 and AFG3L2 causes motor neuron and cerebellar disorders

BackgroundBiallelic SPG7 mutations cause one of the most common forms of hereditary spastic paraplegia (HSP). Several reports have suggested that heterozygous SPG7 variants may also play a role in HSP, but also in amyotrophic lateral sclerosis (ALS). However, it remains controversial whether heterozygous SPG7 mutations are pathogenic on their own, or if other mechanisms are at play. We recently provided evidence for non-Mendelian inheritance in spastic paraplegia 7 (SPG7), as heterozygous carriers of SPG7 mutations often also carried mutations in other disease-related genes, more frequently than expected by chance. AFG3L2 encodes for the AFG3 Like Matrix AAA Peptidase Subunit 2 protein, which creates a proteolytic complex with SPG7-encoded protein paraplegin. In this study, we aimed to examine whether digenic heterozygous mutations in SPG7 and AFG3L2 can lead to a spectrum of neurodegenerative disorders. MethodsWe first analyzed genome and exome sequencing data of 7,515 unrelated individuals including 5,108 motor neuron disorder (MND) and ataxia patients and 2,407 controls. We next analyzed an additional 18,748 exome data from rare disease cohorts to further examine the occurrence of variants in SPG7 and AFG3L2. ResultsAmong the first 5,108 MND and ataxia patients, we identified a total of 10 patients, 8 of whom were unrelated, carried potentially pathogenic variants in both SPG7 and AFG3L2, in contrast to none in 2,407 unrelated controls. Further analysis of the 18,748 additional patients with rare disease, as well as a comprehensive literature review, identified 7 more patients, 6 of whom were unrelated, had digenic mutations in SPG7 and AFG3L2. In the two families we identified, digenic mutations in SPG7 and AFG3L2 perfectly segregated with the disease. The 17 patients reported here exhibited predominant signs of motor neuron and cerebellar involvement. ConclusionsOur findings demonstrate that digenic inheritance of concurrent heterozygous mutations in SPG7 and AFG3L2 may cause motor neuron and cerebellar disorders. Screening of the entire SPG7 and AFG3L2 genes in genetically undiagnosed cases of MND and spastic ataxia may help to increase the diagnostic yield.